Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Proc Natl Acad Sci U S A ; 119(49): e2214935119, 2022 12 06.
Article in English | MEDLINE | ID: mdl-36442094

ABSTRACT

The 53BP1-RIF1 pathway restricts the resection of DNA double-strand breaks (DSBs) and promotes blunt end-ligation by non-homologous end joining (NHEJ) repair. The Shieldin complex is a downstream effector of the 53BP1-RIF1 pathway. Here, we identify a component of this pathway, CCAR2/DBC1, which is also required for restriction of DNA end-resection. CCAR2 co-immunoprecipitates with the Shieldin complex, and knockout of CCAR2 in a BRCA1-deficient cell line results in elevated DSB end-resection, RAD51 loading, and PARP inhibitor (PARPi) resistance. Knockout of CCAR2 is epistatic with knockout of other Shieldin proteins. The S1-like RNA-binding domain of CCAR2 is required for its interaction with the Shieldin complex and for suppression of DSB end-resection. CCAR2 functions downstream of the Shieldin complex, and CCAR2 knockout cells have delayed resolution of Shieldin complex foci. Forkhead-associated (FHA)-dependent targeting of CCAR2 to DSB sites re-sensitized BRCA1-/-SHLD2-/- cells to PARPi. Taken together, CCAR2 is a functional component of the 53BP1-RIF1 pathway, promotes the refill of resected DSBs, and suppresses homologous recombination.


Subject(s)
DNA Breaks, Double-Stranded , Poly(ADP-ribose) Polymerase Inhibitors , DNA End-Joining Repair , Homologous Recombination , DNA
2.
Nature ; 563(7732): 522-526, 2018 11.
Article in English | MEDLINE | ID: mdl-30464262

ABSTRACT

Limited DNA end resection is the key to impaired homologous recombination in BRCA1-mutant cancer cells. Here, using a loss-of-function CRISPR screen, we identify DYNLL1 as an inhibitor of DNA end resection. The loss of DYNLL1 enables DNA end resection and restores homologous recombination in BRCA1-mutant cells, thereby inducing resistance to platinum drugs and inhibitors of poly(ADP-ribose) polymerase. Low BRCA1 expression correlates with increased chromosomal aberrations in primary ovarian carcinomas, and the junction sequences of somatic structural variants indicate diminished homologous recombination. Concurrent decreases in DYNLL1 expression in carcinomas with low BRCA1 expression reduced genomic alterations and increased homology at lesions. In cells, DYNLL1 limits nucleolytic degradation of DNA ends by associating with the DNA end-resection machinery (MRN complex, BLM helicase and DNA2 endonuclease). In vitro, DYNLL1 binds directly to MRE11 to limit its end-resection activity. Therefore, we infer that DYNLL1 is an important anti-resection factor that influences genomic stability and responses to DNA-damaging chemotherapy.


Subject(s)
BRCA1 Protein/deficiency , Cytoplasmic Dyneins/metabolism , DNA/metabolism , Genes, BRCA1 , MRE11 Homologue Protein/metabolism , Recombinational DNA Repair , BRCA1 Protein/genetics , CRISPR-Cas Systems/genetics , Cell Line, Tumor , Chromosome Aberrations , DNA Damage/drug effects , Drug Resistance, Neoplasm/drug effects , Female , Gene Editing , Genomic Instability/drug effects , Homologous Recombination/drug effects , Humans , Mutation , Ovarian Neoplasms/genetics , Ovarian Neoplasms/pathology , Platinum/pharmacology , Poly(ADP-ribose) Polymerase Inhibitors/pharmacology , Protein Binding , Recombinational DNA Repair/drug effects , Transcription Factors/metabolism
3.
Nat Struct Mol Biol ; 30(10): 1456-1467, 2023 10.
Article in English | MEDLINE | ID: mdl-37696958

ABSTRACT

The extent and efficacy of DNA end resection at DNA double-strand breaks (DSB) determine the repair pathway choice. Here we describe how the 53BP1-associated protein DYNLL1 works in tandem with the Shieldin complex to protect DNA ends. DYNLL1 is recruited to DSBs by 53BP1, where it limits end resection by binding and disrupting the MRE11 dimer. The Shieldin complex is recruited to a fraction of 53BP1-positive DSBs hours after DYNLL1, predominantly in G1 cells. Shieldin localization to DSBs depends on MRE11 activity and is regulated by the interaction of DYNLL1 with MRE11. BRCA1-deficient cells rendered resistant to PARP inhibitors by the loss of Shieldin proteins can be resensitized by the constitutive association of DYNLL1 with MRE11. These results define the temporal and functional dynamics of the 53BP1-centric DNA end resection factors in cells.


Subject(s)
BRCA1 Protein , DNA Breaks, Double-Stranded , BRCA1 Protein/metabolism , Tumor Suppressor p53-Binding Protein 1/metabolism , DNA/metabolism , DNA End-Joining Repair , Cell Nucleus/metabolism , DNA Repair
4.
bioRxiv ; 2023 Mar 27.
Article in English | MEDLINE | ID: mdl-37034578

ABSTRACT

Extent and efficacy of DNA end resection at DNA double strand break (DSB)s determines the choice of repair pathway. Here we describe how the 53BP1 associated protein DYNLL1 works in tandem with Shieldin and the CST complex to protect DNA ends. DYNLL1 is recruited to DSBs by 53BP1 where it limits end resection by binding and disrupting the MRE11 dimer. The Shieldin complex is recruited to a fraction of 53BP1-positive DSBs hours after DYNLL1 predominantly in the G1 cells. Shieldin localization to DSBs is dependent on MRE11 activity and is regulated by the interaction of DYNLL1 with MRE11. BRCA1-deficient cells rendered resistant to PARP inhibitors by the loss of Shieldin proteins can be re-sensitized by the constitutive association of DYNLL1 with MRE11. These results define the temporal and functional dynamics of the 53BP1-centric DNA end resection factors in cells.

5.
Nat Cell Biol ; 5(11): 1001-7, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14528312

ABSTRACT

The concentrations and functions of many cellular proteins are regulated by the ubiquitin pathway. Cullin family proteins bind with the RING-finger protein Roc1 to recruit the ubiquitin-conjugating enzyme (E2) to the ubiquitin ligase complex (E3). Cul1 and Cul7, but not other cullins, bind to an adaptor protein, Skp1. Cul1 associates with one of many F-box proteins through Skp1 to assemble various SCF-Roc1 E3 ligases that each selectively ubiquitinate one or more specific substrates. Here, we show that Cul3, but not other cullins, binds directly to multiple BTB domains through a conserved amino-terminal domain. In vitro, Cul3 promoted ubiquitination of Caenorhabditis elegans MEI-1, a katanin-like protein whose degradation requires the function of both Cul3 and BTB protein MEL-26. We suggest that in vivo there exists a potentially large number of BCR3 (BTB-Cul3-Roc1) E3 ubiquitin ligases.


Subject(s)
Caenorhabditis elegans Proteins/metabolism , Ubiquitin-Protein Ligases/metabolism , Ubiquitin/metabolism , Animals , Caenorhabditis elegans , Cells, Cultured
6.
Nat Cell Biol ; 23(8): 818-819, 2021 08.
Article in English | MEDLINE | ID: mdl-34354234

Subject(s)
DNA , DNA/genetics
7.
Mol Cell Biol ; 29(4): 1059-71, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19075002

ABSTRACT

Aurora-A is a conserved kinase implicated in mitotic regulation and carcinogenesis. Aurora-A was previously implicated in mitotic entry and spindle assembly, although contradictory results prevented a clear understanding of the roles of Aurora-A in mammals. We developed a conditional null mutation in the mouse Aurora-A gene to investigate Aurora-A functions in primary cells ex vivo and in vivo. We show here that conditional Aurora-A ablation in cultured embryonic fibroblasts causes impaired mitotic entry and mitotic arrest with a profound defect in bipolar spindle formation. Germ line Aurora-A deficiency causes embryonic death at the blastocyst stage with pronounced cell proliferation failure, mitotic arrest, and monopolar spindle formation. Aurora-A deletion in mid-gestation embryos causes an increase in mitotic and apoptotic cells. These results indicate that murine Aurora-A facilitates, but is not absolutely required for, mitotic entry in murine embryonic fibroblasts and is essential for centrosome separation and bipolar spindle formation in vitro and in vivo. Aurora-A deletion increases apoptosis, suggesting that molecular therapies targeting Aurora-A may be effective in inducing tumor cell apoptosis. Aurora-A conditional mutant mice provide a valuable system for further defining Aurora-A functions and for predicting effects of Aurora-A therapeutic intervention.


Subject(s)
Embryonic Development , Protein Serine-Threonine Kinases/metabolism , Spindle Apparatus/enzymology , Alleles , Animals , Apoptosis , Aurora Kinase A , Aurora Kinases , Blastocyst/cytology , Blastocyst/enzymology , Cell Proliferation , Embryo Loss , Embryo, Mammalian/cytology , Embryo, Mammalian/enzymology , Female , Fibroblasts/cytology , Fibroblasts/enzymology , Gene Deletion , Gene Targeting , Mice , Mitosis , Mutation/genetics , Ploidies , Pregnancy , Protein Serine-Threonine Kinases/deficiency
8.
Genes Dev ; 22(7): 866-71, 2008 Apr 01.
Article in English | MEDLINE | ID: mdl-18381890

ABSTRACT

Tuberous sclerosis (TSC) is an autosomal dominant disease characterized by hamartoma formation in various organs and is caused by mutations targeting either the TSC1 or TSC2 genes. TSC1 and TSC2 proteins form a functionally interdependent dimeric complex. Phosphorylation of either TSC subunit by different kinases regulates the function of TSC and represents a major mechanism to integrate various signals into a centralized cell growth pathway. The majority of disease-associated mutations targeting either TSC1 or TSC2 results in a substantial decrease in protein level, suggesting that protein turnover also plays a critical role in TSC regulation. Here we report that TSC2 protein binds to FBW5, a DDB1-binding WD40 (DWD) protein, and is recruited by FBW5 to the DDB1-CUL4-ROC1 E3 ubiquitin ligase. Overexpression of FBW5 or CUL4A promotes TSC2 protein degradation, and this is abrogated by the coexpression of TSC1. Conversely, depletion of FBW5, DDB1, or CUL4A/B stabilizes TSC2. Ddb1 or Cul4 mutations in Drosophila result in Gigas/TSC2 protein accumulation and cause growth defects that can be partially rescued by Gigas/Tsc2 reduction. These results indicate that FBW5-DDB1-CUL4-ROC1 is an E3 ubiquitin ligase regulating TSC2 protein stability and TSC complex turnover.


Subject(s)
Carrier Proteins/metabolism , Cullin Proteins/metabolism , DNA-Binding Proteins/metabolism , F-Box Proteins/metabolism , Tumor Suppressor Proteins/metabolism , Animals , Blotting, Western , Carrier Proteins/genetics , Cell Line , Cell Line, Tumor , Cullin Proteins/genetics , DNA-Binding Proteins/genetics , Drosophila/genetics , Drosophila/growth & development , Drosophila/ultrastructure , Electrophoresis, Polyacrylamide Gel , F-Box Proteins/genetics , Genetic Complementation Test , HeLa Cells , Humans , Ligases/genetics , Ligases/metabolism , Microscopy, Electron, Scanning , Mutation , Phosphorylation , Protein Binding , RNA Interference , Tuberous Sclerosis Complex 2 Protein , Tumor Suppressor Proteins/genetics , Two-Hybrid System Techniques , Ubiquitin/metabolism , Ubiquitin-Protein Ligases/genetics , Ubiquitin-Protein Ligases/metabolism , Yeasts/genetics
9.
Plant Cell ; 20(1): 152-67, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18223036

ABSTRACT

A subset of WD40 proteins that contain a DWD motif (for DDB1 binding WD40) is reported to act as substrate receptors for DDB1-CUL4-ROC1 (for Damaged DNA Binding 1-Cullin 4-Regulator of Cullins 1) based E3 ubiquitin ligases in humans. Here, we report 85 Arabidopsis thaliana and 78 rice (Oryza sativa) proteins containing the conserved 16-amino acid DWD motif. We show by yeast two-hybrid and in vivo coimmunoprecipitation that 11 Arabidopsis DWD proteins directly interact with DDB1 and thus may serve as substrate receptors for the DDB1-CUL4 machinery. We further examine whether the DWD protein PRL1 (for Pleiotropic Regulatory Locus 1) may act as part of a CUL4-based E3 ligase. PRL1 directly interacts with DDB1, and prl1 and cul4cs mutants exhibited similar phenotypes, including altered responses to a variety of stimuli. Moreover, AKIN10 (for Arabidopsis SNF1 Kinase Homolog 10) was degraded more slowly in cell extracts of prl1 and cul4cs than in cell extracts of the wild type. Thus, both genetic and biochemical analyses support the conclusion that PRL1 is the substrate receptor of a CUL4-ROC1-DDB1-PRL1 E3 ligase involved in the degradation of AKIN10. This work adds a large new family to the current portfolio of plant E3 ubiquitin ligases.


Subject(s)
Amino Acid Motifs , Arabidopsis Proteins/metabolism , Arabidopsis/enzymology , Oryza/enzymology , Plant Proteins/chemistry , Plant Proteins/metabolism , Ubiquitin-Protein Ligases/metabolism , Abscisic Acid/pharmacology , Anthocyanins/metabolism , Arabidopsis/drug effects , Arabidopsis/genetics , Arabidopsis Proteins/chemistry , Carbohydrates/pharmacology , Cotyledon/drug effects , Cotyledon/metabolism , Cullin Proteins/metabolism , Cytokinins/pharmacology , Genes, Plant , Intracellular Signaling Peptides and Proteins/metabolism , Mutation/genetics , Nuclear Proteins/metabolism , Oryza/cytology , Oryza/drug effects , Phenotype , Protein Binding/drug effects , Protein Processing, Post-Translational/drug effects , Seedlings/drug effects , Seedlings/metabolism , Substrate Specificity/drug effects , Transcription, Genetic/drug effects
10.
Genes Dev ; 20(21): 2949-54, 2006 Nov 01.
Article in English | MEDLINE | ID: mdl-17079684

ABSTRACT

Cullins assemble the largest family of ubiquitin ligases by binding with ROC1 and various substrate receptors. CUL4 function is linked with many cellular processes, but its substrate-recruiting mechanism remains elusive. We identified a protein motif, the DWD box (DDB1-binding WD40 protein), and demonstrated the binding of 15 DWD proteins with DDB1-CUL4A. We provide evidence supporting the critical function of the DWD box and DDB1's role as the linker mediating DWD protein association with CUL4A. A database search predicts that about one-third of WD40 proteins, 90 in humans, contain the DWD box, suggesting a potentially large number of DWD-DDB1-CUL4-ROC1 E3 ligases.


Subject(s)
Carrier Proteins/metabolism , Cullin Proteins/metabolism , DNA-Binding Proteins/metabolism , Ubiquitin-Protein Ligases/metabolism , Amino Acid Motifs , Amino Acid Sequence , Conserved Sequence , DNA-Binding Proteins/chemistry , DNA-Binding Proteins/genetics , HeLa Cells , Humans , Molecular Sequence Data
SELECTION OF CITATIONS
SEARCH DETAIL